Elective lung cancer surgery in the COVID-19 era: how do we do it?

Rajdeep Bilkhu; Andrea Billè

doi:10.1177/0300891620931568

Elective lung cancer surgery in the COVID-19 era: how do we do it?

Tumori. 2020 May 28:300891620931568. doi: 10.1177/0300891620931568. Online ahead of print.

Authors

Rajdeep Bilkhu¹, Andrea Billè^{1

2}

Affiliations

¹ Department of Thoracic Surgery, Guy's Hospital, London, UK.
² Division of Cancer Studies, King's College London, Guy's Hospital, London, UK.

PMID: 32462984
DOI: 10.1177/0300891620931568

Abstract

The coronavirus 2019 (COVID-19) pandemic has caused significant mortality around the world and the focus has been on reducing the number of infections. In order not to compromise treatment of oncology patients, reducing the number of patients with COVID-19 undergoing treatment is mandatory. We reviewed the experience of the National Institute of Cancer in Milan and compared it with our experience.

Keywords: COVID-19; CT scan; thoracic oncology; thoracic surgery.

Publication types

Editorial